Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by AKORN INC

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
016796 New Drug Application Approval New formulation (S) Standard review drug
021716 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
040277 Abbreviated New Drug Application Approval
065006 Abbreviated New Drug Application Approval
065305 Abbreviated New Drug Application Approval
075086 Abbreviated New Drug Application Approval
075431 Abbreviated New Drug Application Approval
075481 Abbreviated New Drug Application Approval
075494 Abbreviated New Drug Application Approval
075524 Abbreviated New Drug Application Approval
076555 Abbreviated New Drug Application Approval
077764 Abbreviated New Drug Application Approval
079078 Abbreviated New Drug Application Approval
079119 Abbreviated New Drug Application Approval
079197 Abbreviated New Drug Application Approval
079217 Abbreviated New Drug Application Approval
083590 Abbreviated New Drug Application Approval
090163 Abbreviated New Drug Application Approval
201422 Abbreviated New Drug Application Approval
202548 Abbreviated New Drug Application Approval
202585 Abbreviated New Drug Application Approval
202795 Abbreviated New Drug Application Approval
202916 Abbreviated New Drug Application Approval
203048 Abbreviated New Drug Application Approval
203058 Abbreviated New Drug Application Approval
203173 Abbreviated New Drug Application Approval
203929 Abbreviated New Drug Application Approval
203955 Abbreviated New Drug Application Approval
204723 Abbreviated New Drug Application Tentative Approval
204731 Abbreviated New Drug Application Tentative Approval
204912 Abbreviated New Drug Application Approval
205937 Abbreviated New Drug Application Approval
207926 New Drug Application Approval Drug already marketed, but without an approved NDA (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval